MRI accuracy in residual disease evaluation in breast cancer patients treated with neoadjuvant chemotherapy

P. Belli; M. Costantini; C. Malaspina; A. Magistrelli; G. LaTorre; L. Bonomo

doi:10.1016/j.clinimag.2006.12.008

Abstract| Volume 31, ISSUE 2, P145, March 2007

Download started.

Ok

MRI accuracy in residual disease evaluation in breast cancer patients treated with neoadjuvant chemotherapy

P. Belli
P. Belli
Affiliations
(Department of Bio-Imaging and Radiological Sciences, Catholic University, L.go A Gemelli 8, I-00168 Rome, Italy). Clin Radiol 2006;61:946–953.
Search for articles by this author
M. Costantini
M. Costantini
Affiliations
(Department of Bio-Imaging and Radiological Sciences, Catholic University, L.go A Gemelli 8, I-00168 Rome, Italy). Clin Radiol 2006;61:946–953.
Search for articles by this author
C. Malaspina
C. Malaspina
Affiliations
(Department of Bio-Imaging and Radiological Sciences, Catholic University, L.go A Gemelli 8, I-00168 Rome, Italy). Clin Radiol 2006;61:946–953.
Search for articles by this author
A. Magistrelli
A. Magistrelli
Affiliations
(Department of Bio-Imaging and Radiological Sciences, Catholic University, L.go A Gemelli 8, I-00168 Rome, Italy). Clin Radiol 2006;61:946–953.
Search for articles by this author
G. LaTorre
G. LaTorre
Affiliations
(Department of Bio-Imaging and Radiological Sciences, Catholic University, L.go A Gemelli 8, I-00168 Rome, Italy). Clin Radiol 2006;61:946–953.
Search for articles by this author
L. Bonomo
L. Bonomo
Affiliations
(Department of Bio-Imaging and Radiological Sciences, Catholic University, L.go A Gemelli 8, I-00168 Rome, Italy). Clin Radiol 2006;61:946–953.
Search for articles by this author

Published:January 22, 2007DOI:https://doi.org/10.1016/j.clinimag.2006.12.008

Aim: This study aimed to assess the accuracy of magnetic resonance imaging (MRI) in evaluating residual disease after neoadjuvant chemotherapy in patients with large breast cancers.

To read this article in full you will need to make a payment

Purchase one-time access:

One-time access price info

For academic or personal research use, select 'Academic and Personal'
For corporate R&D use, select 'Corporate R&D Professionals'

Subscribe:

Already a print subscriber? Claim online access

Already an online subscriber? Sign in

Register: Create an account

Institutional Access: Sign in to ScienceDirect

Article info

Publication history

Published online: January 22, 2007

Identification

DOI: https://doi.org/10.1016/j.clinimag.2006.12.008

Copyright

ScienceDirect

Access this article on ScienceDirect

Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

MRI accuracy in residual disease evaluation in breast cancer patients treated with neoadjuvant chemotherapy

Purchase one-time access:

Subscribe:

Article info

Publication history

Identification

Copyright

ScienceDirect

Related Articles